Figma Shares Indicated To Open $105/$110
Investing.com - Pfizer reported on Tuesday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Pfizer announced earnings per share of $0.42 on revenue of $11.68B. Analysts polled by Investing.com EPS of $0.5183 on revenue of $12.24B.
Pfizer 's are down 2% and is trading at $35.80 , still down 16.78% from its 52 week high of $43.02 set on Wednesday, December 9, 2020.
Pfizer follows other major Healthcare sector earnings this month
Pfizer's report follows an earnings beat by J&J on Tuesday, January 26, 2021, who reported EPS of $1.86 on revenue of $22.48B, EPS of $1.82 on revenue of $21.66B.
Abbott Labs had beat expectations on Wednesday, January 27, 2021 with fourth quarter EPS of $1.45 on revenue of $10.7B, for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar